Skip to main content

Resmed Value Stock - Dividend - Research Selection

Resmed

ISIN: US7611521078, WKN: 895878

Market price date: 23.07.2021
Market price: 259,83 USD




Resmed Fundamental data and company key figures of the share

Annual reports in USD
Key figures 26-03-2021
Cash flow
Net operating cash flow 802.255.000
Capital Expenditures -105.938.000
Free cash flow 696.316.992
Balance sheet
Total Equity 2.497.030.000
Liabilities & Shareholders equity 4.587.380.000
Income statement
Net income 621.674.000
Eps (diluted) 4,270
Diluted shares outstanding 145.650.000
Net sales/revenue 2.957.010.000

Fundamental ratios calculated on: 23-07-2021

Ratios
Key figures 23-07-2021
Cash flow
P/C 47,17
   
P/FC 54,35
Balance sheet
ROI13,55
ROE54,43
Income statement
P/E60,85
Div. Yield0,60%
P/B15,16
P/S12,80


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolRMD
Market Capitalization37.844.238.336,00 USD
Country
IndicesS&P 500
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split2010-08-31,2.000000/1.000000; 2005-10-03,2.000000/1.000000; 2000-04-03,2.000000/1.000000; 1998-11-17,2.000000/1.000000
Internetwww.resmed.com


Description of the company

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.resmed.com